Linden Advisors’s Frazier Lifesciences Acquisition Corp Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-64,960
Closed -$79K – 755
2021
Q2
$79K Hold
64,960
– – ﹤0.01% 785
2021
Q1
$60K Buy
+64,960
New +$110K ﹤0.01% 702

Other funds holding FLACW

Linden Advisors's FLACW Position: Q3 2021 in Review

Linden Advisors sold out of Frazier Lifesciences Acquisition Corp Warrant (FLACW) in Q3 2021, closing a stake of 64,960 shares — an estimated $79K sold.

Linden Advisors first reported a position in FLACW in Q1 2021 and held it in 2 quarters. The position peaked at $79K in Q2 2021. 24 funds tracked by Wall St. Rank hold FLACW as of Q3 2021.

  • Linden Advisors reported no remaining Frazier Lifesciences Acquisition Corp Warrant position as of Q3 2021 after selling out during the quarter.
  • Linden Advisors sold 64,960 Frazier Lifesciences Acquisition Corp Warrant shares in Q3 2021, an estimated $79K.
  • Linden Advisors first reported a position in Frazier Lifesciences Acquisition Corp Warrant in Q1 2021 and held it in 2 quarters.
  • Linden Advisors's Frazier Lifesciences Acquisition Corp Warrant position peaked at $79K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corp Warrant as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.